Member Info for wozzer70

Onwards and upwards 💫

Few things stood out to me from the results:

Guident revenue growth +862% Microsalt projected at $7m sales in 2026 and >$15m in 2027 GenIP revenue growth +330% TEK operating costs reduced again for third consecutive year

This no longer feels like the market questioning whether the portfolio exists.

It feels like the market waiting for external validation that the framework can monetise successfully.

That’s why Guident now matters so much

Feels like the board is split into 3 camps now:

holders exhausted by the delays,people accumulating because of the NAV gap,and others waiting for actual proof before they’ll rerate TEK.

Personally, I don’t read the filings as a business collapsing operationally.

I read it as a market that no longer wants “future potential” stories and instead wants external validation that the framework can actually monetise successfully.

That’s why Guident matters so much in my view.

Not Vesari.Not another portfolio update.Not another presentation.

A successful Guident listing would finally give the market a real valuation benchmark and could materially reduce the credibility discount hanging over TEK.

Of course, that alone doesn’t solve everything. The next question would then become whether TEK can monetise value successfully over time.

But for me, that’s the key fork in the road now.

My honest overall read:

This RNS does not read like a collapsing company.

It reads like a venture/IP holding structure approaching the point where operational traction now needs to convert into externally validated financial outcomes.

That’s the fork in the road.

The next 6-12 months probably matter more for TEK than the previous several years combined, because the market has clearly moved beyond:

“interesting framework”

and into:

“prove the framework works financially.”

If Guident successfully lists and holds value, sentiment could shift materially because it would validate years of incubation effort and begin reducing the credibility discount currently applied to TEK.

If not, the market likely continues treating the portfolio as long-duration optionality regardless of underlying progress.

That’s where the story now sits in my view.

Appreciate that Frank, and likewise I genuinely wish you well with your future investments too.

Most of my investing is actually focused on the US markets rather than the UK, but I’ve stayed with TEK because I still believe the broader framework makes more sense once viewed as a full long-duration portfolio/incubation model rather than through isolated events.

For me, Guident remains the key missing piece the market is waiting to see resolved and, if successful, could become the first major external validation point for the wider structure.

Fair post Frank, and I think most long-term holders understand the frustration around dilution, timelines and lack of realised shareholder returns so far.

Where opinions probably diverge is on whether TEK should be judged mainly on its historical cash outcomes to date, or on whether the portfolio model can still reach a broader external validation phase.

For me, that’s why Guident matters so much.

A successful listing would not suddenly solve every issue overnight, but it could materially change how the market views the wider portfolio structure and close part of the credibility/NAV discount over time.

That’s the part I think the market is still waiting to see resolved

I think that framing oversimplifies what TEK has actually been doing over the last decade.

The model was never a dividend income vehicle, it was an IP commercialisation/incubation structure focused on building portfolio companies toward potential liquidity events.

Bell, Lucyd, GenIP, Salt and Guident effectively became the development cycle itself, which naturally required repeated capital raises and long timelines.

The real debate now is not whether dilution historically happened, everyone can see that it did. The question is whether the model can ultimately convert portfolio development into externally validated monetisation events and long-term shareholder value.

That’s why so much market focus sits on Guident.

Fair points to raise, although I think it comes down to whether TEK is viewed as a short-term monetisation vehicle or a longer-duration venture/incubation structure.

Retaining positions post-IPO can extend timelines and dilution exposure, but management may also believe greater value creation still sits further out rather than at initial listing.

Ultimately the market probably needs to see a full cycle completed successfully before confidence in the model materially improves

I think TEK historically focused more on developing a concentrated group of portfolio companies toward maturity/liquidity events rather than continuously adding new early-stage startups every year.

Bell, Lucyd, GenIP, Salt and Guident effectively were the pipeline for most of that cycle.

The bigger question going forward is whether successful monetisation events eventually allow the portfolio model to recycle capital into a new generation of opportunities.

Stepping back, I think it helps to separate TEK into three layers: what’s real, what’s uncertain, and how markets typically respond.

Tekcapital is fundamentally a portfolio / IP commercialisation model, where value is tied to future monetisation events rather than day-to-day operations.

Guident is currently the key near-term catalyst, but until a liquidity event completes it remains a process-dependent valuation rather than a priced asset.

Everything else (including newer initiatives like Vesari) sits further out on the timeline in early-stage or development territory.

Markets in these structures tend to behave in phases:

*heavy discount during uncertainty

*repricing on validation events (if they land)

*then a slower reassessment based on post-event reality

So the real question isn’t sentiment or noise, it’s whether TEK can demonstrate repeated external validation of its portfolio model over time.

Until then, the market is essentially pricing uncertainty, not just assets.

On the new venture (Vesari), it’s interesting structurally, but at this stage it remains pre-commercial, IP-heavy, and long-dated.

For me, it’s not the current near-term sentiment driver for TEK, with Guident still sitting as the key potential catalyst being watched. 🧐

If a successful Guident listing is achieved, the key change is likely to be how the market prices uncertainty across the wider TEK structure.

In situations like this, markets don’t usually move in a straight line to “fair value”. Instead they tend to re-rate in steps as external validation reduces perceived risk and improves visibility of underlying asset quality.

So the first impact is typically not full value realisation, but a shift in sentiment and discount rate applied to the wider portfolio, as the market begins to reassess what was previously being priced as purely theoretical

For me, history, structure and present signals all need to be read together.

Fundraises are part of a capital cycle, not just isolated events.

Portfolio development reflects long-duration incubation, not instant monetisation.

Delays in these structures are often process friction, not necessarily intent or failure.

And an IPO, if/when it lands, should be viewed as a validation milestone within that cycle, not an isolated hope event.

That’s the framework I’m using when I look at TEK and Guident.

The market clearly wants proof now, which is understandable after such a long process.

For me though, companies generally do not invest this much time, cost and effort advancing a listing process unless they believe there is meaningful long-term value on the other side. Until proven otherwise, I still view Guident as the key potential catalyst for wider TEK sentiment.

All filings so far still suggest we are moving forward, only stalled because of 900 IPO'S Backlog.

Vesari strengthens the broader TEK story today, but for me Guident remains the key trigger.

A successful IPO would provide the market with an externally validated valuation benchmark for a major TEK holding and could be the point where Phase 1 of any rerate starts to appear in the share price as the wider sum-of-parts becomes harder to ignore.

I think the market is simply waiting for proof now.

If Guident lists successfully, the market finally gets an external valuation benchmark for one of TEK’s core assets rather than relying on assumptions. That alone could cause investors to reassess the wider sum-of-parts value across the portfolio.

Until then, the discount probably remains because uncertainty remains.

Https://www.investor.gov/introduction-investing/investing-basics/glossary/quiet-period

Https://www.bitget.com/stock/lse-tek/what-is

If you ask Tuffax for the time of day,

He’ll tell you why Belluscura won't pay.

If you ask Aspers for the price of a pint,

He’ll scream that the "NAV is out of alignment!"

Poor souls.

They’re so busy fighting the posters they hate,

They forgot to check the EDGAR gate.

MicroSalt covers the cap - it’s a fact,

But they’re too busy "trolling" to learn how to act.

It’s been "emotional" watching you two fail,

Don't forget to send me your salt in the mail.

🎤✨

The Valuation Gap: TEK often trades at a significant discount to its Net Asset Value (NAV). A successful Guident IPO is the primary catalyst to "force" the market to acknowledge that NAV.

The Underwriter Factor: Boral Capital wouldn't still be lead-left if the deal was dead; they only get paid when the ticker goes live.

The Timing: We are currently in the "Spring Window." Historically, if a company has fresh audited numbers (which Guident does), this is the prime time to push for "Effectiveness."

If the IPO prices at the $4–$5 range, TEK’s stake should see a significant paper uplift.